Mark Shapiro, Liquidating Trustee of the Alliance v. Wall Street Health Services

CourtUnited States Bankruptcy Court, S.D. Texas
DecidedJanuary 21, 2021
Docket19-03431
StatusUnknown

This text of Mark Shapiro, Liquidating Trustee of the Alliance v. Wall Street Health Services (Mark Shapiro, Liquidating Trustee of the Alliance v. Wall Street Health Services) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, S.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mark Shapiro, Liquidating Trustee of the Alliance v. Wall Street Health Services, (Tex. 2021).

Opinion

= □□ □□□ □□□□□□ □□ □□ □□ IN THE UNITED STATES BANKRUPTCY COURT □□ Ay FOR THE SOUTHERN DISTRICT OF TEXAS HOUSTON DIVISION ENTERED 01/21/2021 IN RE: § UPLIFT RX, LLC, et al, Debtors. § CASE NO: 17-32186 § § CHAPTER 11

MARK SHAPIRO, LIQUIDATING § TRUSTEE OF THE ALLIANCE HEALTH § LIQUIDATING TRUST, § Plaintiff, § § VS. § ADVERSARY NO. 19-3431 § WALL STREET HEALTH SERVICES, § Defendant. § MEMORANDUM OPINION The Liquidating Trustee of the Alliance Health Liquidating Trust, Mark Shapiro, seeks leave to amend the complaint. Specifically, the Trustee wants to add new claims and new defendants to this adversary proceeding. Wall Street Health Services LLC (“Wall Street”) opposes the Trustee’s motion. The parties’ dispute centers on three issues: (1) whether “good cause” exists to allow the Trustee to amend the complaint after the expiration of the pleading amendment deadline; (2) whether the claims the Trustee seeks to add arise out of the same “conduct, transaction, or occurrence” pleaded in the Original Complaint; and (3) whether the new defendants received the “notice” required by Federal Rule of Civil Procedure 15(c). There is “good cause” to allow the Trustee to amend the complaint, in part, after the deadline set by the Court’s Scheduling Order. The new claims the Trustee hopes to add are not part of the same “conduct, transaction, or occurrence” set out in the Original Complaint. Two of the defendants the Trustee seeks to add—PetersonRX LLC and Dow Jones—received notice of the Original Complaint. The remaining prospective defendants did not. The Trustee is Granted

1/27

leave to add PetersonRX and Dow Jones as defendants, but the Trustee is Denied leave to add the additional claims and remaining additional defendants. BACKGROUND The Original Complaint sought to avoid and recover certain fraudulent and preferential transfers made by the Debtor, Uplift RX, LLC, and certain of its debtor affiliates (collectively,

“the Debtors”).1 The Original Complaint alleged that Wall Street was the sole transferee of these transfers (the “Original Transfers”). (See ECF No. 1). After exchanging discovery with Wall Street, the Trustee discovered additional transfers, which the Trustee now seeks to avoid, as well as additional transferees, which the Trustee now seeks to join as defendants. (ECF No. 23 at 3). The Original Complaint The Original Complaint was filed on April 5, 2019. (ECF No. 1).2 It alleged that Uplift RX, LLC, Richardson Pharmacy LLC, New Jersey Rx, LLC, Kendall Pharmacy, Inc., Skyline Health Services, and Alliance Medical Administration, Inc. made preferential and fraudulent transfers to Wall Street. (ECF No. 1 at 6–24). These transfers were identified using the Debtors’

accounts payable records, which identified Wall Street as the transferee. (ECF Nos. 23 at 5; 23-2 at 1–3). The Original Complaint and Summons were on served Wall Street through its principal and registered agent, Dow Jones, on April 11, 2019. (ECF No. 4 at 2). Wall Street delayed almost seven months before answering the Original Complaint. (See ECF No. 14). Because of its delay, Wall Street was required to seek leave to file a late answer.

1 The other Debtors implicated in this adversary proceeding include Richardson Pharmacy LLC (Case No. 17-32193), New Jersey Rx, LLC (Case No. 17-32206), Skyline Health Services, LLC (Case No. 17-32212), Kendall Pharmacy, Inc (Case No. 17-32198), Alliance Medical Administration, Inc. (Case No. 17-32246), Benson Pharmacy, Inc. (Case No. 17-32191). (ECF Nos. 1 at 2; 23-1 at 2, 38). The order for relief in Skyline’s case was entered on April 8, 2017. The orders for relief in the remaining Debtors’ cases were entered on April 7, 2017.

2 The Original Complaint was filed by the Debtors. (ECF No. 1). However, Mark Shapiro, the liquidating trustee, was substituted for the Debtors as Plaintiff. (ECF No. 9 at 1–2). (See ECF No. 16). The Trustee did not oppose Wall Street’s request for leave to file its answer. (ECF No. 16 at 2). After Wall Street answered, the Court entered a comprehensive Scheduling Order. The Scheduling Order set the deadline for pleading amendments for February 24, 2020 and the discovery deadline for June 24, 2020. (ECF No. 20 at 1). On January 9, 2020, the Trustee served

its first set of discovery requests on Wall Street. (ECF No. 23 at 10). Wall Street produced its responses on February 10, 2020 (ECF No. 27 at 2). The Additional Transfers and Defendants In its discovery responses, Wall Street asserted that it did not receive the benefit of certain transfers identified in the Original Complaint. (ECF No. 27 at 2). Based on Wall Street’s responses, the Trustee began investigating the accuracy of Wall Street’s assertion. (ECF No. 23 at 2). Along with this investigation, the Trustee sought to depose Dow Jones, Wall Street’s principal and registered agent. (ECF No. 23 at 5). As of the filing of the Trustee’s Motion for Leave to Amend, the Trustee had not yet deposed Mr. Jones. (ECF No. 23 at 9).

Through this investigation, the Trustee discovered that Wall Street “was not the initial transferee of a number of the [Original] Transfers.” (ECF No. 23 at 5). The Trustee also discovered 13 additional preferential or fraudulent transfers (the “Additional Transfers”). (ECF No. 23 at 4–6). These discoveries led the Trustee to seek leave to amend the Original Complaint. (ECF No. 23 at 6). Specifically, the Trustee wants to add the newly discovered transferees of the Original Transfers as defendants (the “Additional Defendants”),3 as well as new avoidance claims based on the Additional Transfers. (ECF No. 23 at 6).

3 The Additional Defendants are Dow Jones, individually; Kathryn Jones, individually; PetersonRX, LLC; Twin Lakes, LLC; David Pharmacy, LLC; Alameda Pharmacy LLC; El Dorado Pharmacy LLC; and Baytree Pharmacy LLC. (ECF No. 23 at 8). The Trustee’s Motion for Leave to Amend On June 10, 2020, the Trustee sought leave to amend the complaint. (See ECF No. 23). Because the Trustee did not amend the Original Complaint before the pleading amendment deadline in the Scheduling Order, the Trustee must be granted leave to amend. In support of the request for leave, the Trustee argues that “good cause” exists to authorize this post-deadline

amendment. (ECF No. 23 at 13–15). The Trustee primarily argues that “good cause” exists because the delay in moving to amend resulted from the need for an additional investigation based on Wall Street’s discovery responses. (ECF No. 23 at 13–14). As a basis for including the Additional Transfers, the Trustee argues that the Additional Transfers arise from the same “conduct, occurrence, or transaction” alleged in the Original Complaint. (ECF No. 23 at 11). The Trustee alleges that the same “conduct, transaction, or occurrence” from which the Additional Transfers arose was a “convoluted payment scheme.” (ECF No. 23 at 6). Through this “convoluted payment scheme,” the Debtors would transfer funds to multiple entities, those entities would then transfer funds to a single entity, and then that single

entity would use the funds to pay down credit card debt held by Mr. Jones, Kathryn Jones (Dow Jones’s wife), and other entities associated with the Joneses. (ECF No. 23 at 5–6). The existence of this “scheme” was not alleged in the Original Complaint. As for the inclusion of the Additional Defendants, the Trustee argues that the Additional Defendants received adequate notice of the Trustee’s action through their relationships with Mr. Jones. (ECF No. 23 at 15–20). Specifically, the Trustee asserts that Mr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Jacobsen v. Osborne
133 F.3d 315 (Fifth Circuit, 1998)
Mayeaux v. Louisiana Health Service & Indemnity Co.
376 F.3d 420 (Fifth Circuit, 2004)
Smith v. EMC Corporation
393 F.3d 590 (Fifth Circuit, 2004)
Whitt v. Stephens County
529 F.3d 278 (Fifth Circuit, 2008)
Sanders-Burns v. City of Plano
594 F.3d 366 (Fifth Circuit, 2010)
KRUPSKI v. COSTA CROCIERE S. P. A
560 U.S. 538 (Supreme Court, 2010)
Dwan Tapp v. Gulf Stream Coach, Inc.
401 F. App'x 930 (Fifth Circuit, 2010)
In Re Allbrand Appliance & Television Company, Inc.
875 F.2d 1021 (Second Circuit, 1989)
Goodman v. Praxair, Inc.
494 F.3d 458 (Fourth Circuit, 2007)
Bush v. Sumitomo Bank and Trust Co., Ltd.
513 F. Supp. 1051 (E.D. Texas, 1981)
Advanced Power Systems, Inc. v. Hi-Tech Systems, Inc.
801 F. Supp. 1450 (E.D. Pennsylvania, 1992)
In Re Chaus Securities Litigation
801 F. Supp. 1257 (S.D. New York, 1992)

Cite This Page — Counsel Stack

Bluebook (online)
Mark Shapiro, Liquidating Trustee of the Alliance v. Wall Street Health Services, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mark-shapiro-liquidating-trustee-of-the-alliance-v-wall-street-health-txsb-2021.